These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 318920)

  • 81. Induction of urinary bladder tumors in ACI-N rats by butyl(3-carboxypropyl)nitrosoamine, a major urinary metabolite of butyl-(4-hydroxybutyl)nitrosoamine.
    Hashimoto Y; Suzuki E; Okada M
    Gan; 1972 Oct; 63(5):637-8. PubMed ID: 4645279
    [No Abstract]   [Full Text] [Related]  

  • 82. The mutagenicity of heterocyclic N-nitrosamines for Salmonella typhimurium.
    Zeiger E; Sheldon AT
    Mutat Res; 1978 Mar; 57(1):1-10. PubMed ID: 347283
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Induction of tumours by administration of N-dibutylnitrosamine and derivatives to infant mice.
    Fujii K; Odashima S; Okada M
    Br J Cancer; 1977 May; 35(5):610-4. PubMed ID: 861148
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of various carcinogenic and non-carcinogenic substances on development of bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosoamine.
    Ito N; Matayoshi K; Matsumura K; Denda A; Kani T
    Gan; 1974 Apr; 65(2):123-30. PubMed ID: 4837987
    [No Abstract]   [Full Text] [Related]  

  • 85. Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
    Ito N; Hiasa Y; Tamai A; Okajima E; Kitamura H
    Gan; 1969 Aug; 60(4):401-10. PubMed ID: 5345658
    [No Abstract]   [Full Text] [Related]  

  • 86. Alpha-oxidative metabolism of the bladder carcinogens N-nitrosobutyl(4-hydroxybutyl)amine and N-nitrosobutyl(3-carboxypropyl)amine within the rat isolated bladder.
    Airoldi L; Magagnotti C; Bonfanti M; Fanelli R
    Carcinogenesis; 1990 Aug; 11(8):1437-40. PubMed ID: 2387032
    [TBL] [Abstract][Full Text] [Related]  

  • 87.
    Wakui S; Takahashi H; Muto T
    Toxicol Pathol; 2022 Apr; 50(3):366-380. PubMed ID: 35045775
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A correlation between mutagenic and carcinogenic potencies in a diverse group of N-nitrosamines: determination of mutagenic activities of weakly mutagenic N-nitrosamines.
    Lee SY; Guttenplan JB
    Carcinogenesis; 1981; 2(12):1339-44. PubMed ID: 7034988
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Interstitial stroma and carcinogenesis: ultrastructural observations in the rat bladder treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Zhang XH; Takenaka I
    Urol Res; 1996; 24(3):177-81. PubMed ID: 8839486
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A simple method for detection and analysis of carcinogenic nitrofuran compounds and their metabolites by combining chromatography and spot mutation tests.
    Hayashida S; Wang CY; Bryan GT
    Gan; 1976 Aug; 67(4):617-9. PubMed ID: 799604
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A functional and quantitative mutational analysis of p53 mutations in yeast indicates strand biases and different roles of mutations in DMBA- and BBN-induced tumors in rats.
    Yamamoto K; Nakata D; Tada M; Tonoki H; Nishida T; Hirai A; Ba Y; Aoyama T; Hamada J; Furuuchi K; Harada H; Hirai K; Shibahara N; Katsuoka Y; Moriuchi T
    Int J Cancer; 1999 Nov; 83(5):700-5. PubMed ID: 10521810
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Morphology, classification and histogenesis of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced carcinomas in the urinary bladder of rats.
    Knuze E; Schauer A
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977; 88(3):273-89. PubMed ID: 140544
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mutagenicity of carcinogenic azo dyes and their derivatives.
    Yahagi T; Degawa M; Seino Y; Matsushima T; Nagao M
    Cancer Lett; 1975 Nov; 1(2):91-6. PubMed ID: 828073
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Co-mutagenic effect of norharman with N-nitrosamine derivatives.
    Wakabayashi K; Nagao M; Kawachi T; Sugimura T
    Mutat Res; 1981 Jan; 80(1):1-7. PubMed ID: 7010130
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Mutagenicity of aliphatic nitrosamines in Salmonella typhimurium.
    Rao TK; Young JA; Lijinsky W; Epler JL
    Mutat Res; 1979 Jan; 66(1):1-7. PubMed ID: 370582
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Mutagenicities of quinoline and its derivatives.
    Nagao M; Yahagi T; Seino Y; Sugimura T; Ito N
    Mutat Res; 1977 Mar; 42(3):335-42. PubMed ID: 323699
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparative mutagenicity of N-nitrosamines in a semi-solid and in a liquid incubation system in the presence of rat or human tissue fractions.
    Bartsch H; Camus A; Malaveille C
    Mutat Res; 1976 Nov; 37(2-3):149-62. PubMed ID: 794701
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Metabolic fate of asymmetric N,N-dialkylnitrosamines having butyl group in the rat.
    Suzuki E; Okada M
    Gan; 1981 Dec; 72(6):910-20. PubMed ID: 7341340
    [TBL] [Abstract][Full Text] [Related]  

  • 99. High mutagenicity of N-(alpha-acyloxy)alkyl-N-alkylnitrosamines in S. typhimurium: model compounds for metabolically activated N,N-dialkylnitrosamines.
    Camus AM; Wiessler M; Malaveille C; Bartsch H
    Mutat Res; 1978 Feb; 49(2):187-94. PubMed ID: 342933
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Human, rat and mouse liver-mediated mutagenicity of vinyl chloride in S. typhimurium strains.
    Bartsch H; Malaveille C; Montesano R
    Int J Cancer; 1975 Mar; 15(3):429-37. PubMed ID: 1095499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.